Choline salicylate 29 MG/ML / guaifenesin 6.67 MG/ML Oral Solution — RxCUI 2670549
RxNorm drug concept · Semantic clinical drug
RxCUI 2670549
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2670549
Official nameCholine salicylate 29 MG/ML / guaifenesin 6.67 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascholine salicylate 870 MG / guaifenesin 200 MG per 30 ML Oral Solution; choline salicylate 870 MG / guaiFENesin 200 MG in 30 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Guaifenesin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Guaifenesin is what's called an expectorant — it works to thin and loosen the mucus sitting in your chest and airways. That makes it easier to cough the mucus up and out, so instea...
- What exactly does guaifenesin do for my cough?
- Guaifenesin is meant for short-term use. If your cough isn't getting better after 7 days, keeps coming back, or shows up alongside a fever, rash, or a headache that won't go away,...
- How long can I take it before I should call my doctor?
🕸️ Concept Web — How Choline salicylate 29 MG/ML / guaifenesin 6.67 M... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Choline salicylate 29 MG/ML / guaifenesin 6.67 MG/ML Oral Solution
RxCUI 2670549 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Choline
2449IN -
Guaifenesin
5032IN -
Choline / guaifenesin
2670542MIN -
Choline salicylate
20974PIN
-
Choline
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Choline / guaifenesin Oral Solution
2670545SCDF -
Choline salicylate / guaifenesin Oral Solution
2670548SCDFP -
Choline / guaifenesin Oral Liquid Product
2670544SCDG -
Choline / guaifenesin Oral Product
2670543SCDG -
Choline salicylate / guaifenesin Oral Liquid Product
2670547SCDGP -
Choline salicylate / guaifenesin Oral Product
2670546SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Choline / guaifenesin Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Choline salicylate 29 MG/ML
1653128SCDC -
Guaifenesin 6.67 MG/ML
330540SCDC
-
Choline salicylate 29 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Choline salicylate 29 MG/ML
SCDC · 1653128 -
Guaifenesin 6.67 MG/ML
SCDC · 330540 -
Choline / guaifenesin Oral Solution
SCDF · 2670545 -
Choline salicylate / guaifenesin Oral Solution
SCDFP · 2670548 -
Choline / guaifenesin Oral Liquid Product
SCDG · 2670544 -
Choline / guaifenesin Oral Product
SCDG · 2670543 -
Choline salicylate / guaifenesin Oral Liquid Product
SCDGP · 2670547 -
Choline salicylate / guaifenesin Oral Product
SCDGP · 2670546
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2670549 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58809-0218-08 | 237 mL in 1 BOTTLE, PLASTIC (58809-218-08) | TexaClear Pain and Chest Congestion Relief | GM Pharmaceuticals, INC | 2023-10-25 |
Observed labelers:
GM Pharmaceuticals, INC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.